UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041258
Receipt number R000047091
Scientific Title A single-arm feasibility trial of workplace tobacco control programs using a workplace checklist
Date of disclosure of the study information 2020/07/30
Last modified on 2022/08/05 08:28:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Workplace interventions to promote tobacco control: a feasibility trial using a workplace checklist

Acronym

Workplace interventions to promote tobacco control: a feasibility trial

Scientific Title

A single-arm feasibility trial of workplace tobacco control programs using a workplace checklist

Scientific Title:Acronym

A single-arm feasibility trial of workplace tobacco control programs

Region

Japan


Condition

Condition

Healthy participants

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the feasibility of workplace tobacco control programs in small or medium-sized companies

Basic objectives2

Others

Basic objectives -Others

Feasibility

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Employer fidelity to the checklist items at 6 months after the intervention

Key secondary outcomes

- Acceptability of the intervention program: employer satisfaction at 6 months after the intervention
- Feasibility of the intervention program: number of consultations during the intervention
- Implementation outcome: implementation scores of tobacco control at 6 months after the intervention
- Process outcome: response rate of the employees survey at the baseline
- Health behavior outcomes: proportion of employees who visited smoking cessation clinics at 6 months after the intervention, proportion of employees who quit smoking at 12 months after the intervention


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

The interventionist will offer support to the employers and health managers to adopt and implement the following three evidence-based tobacco control measures: (1) smoke-free workplace, (2) financial assistance on smoking cessation, and (3) incentive schemes. In order to provide support tailored to the needs of the company, the interventionist will propose behavioral change techniques to the employers and health managers during the consultations based on their responses to the workplace checklist. The intervention period will be of 6 months. Consultations will be held approximately once a week in the first month followed by once every 1-3 months.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Inclusion criteria for companies
1) A small or medium-sized company or a branch or business office of a company, with 10 or more and 300 or fewer employees
2) Existence of a physical building, wherein the employees work
3) In business for more than 3 years
4) Assent of the employer (branch or office manager) to promote tobacco control

Inclusion criteria for intervention targets
Employers
1) The employer (branch or business manager) of the company participating in the trial

Health managers
1) Employees responsible and actually working for management and promotion of health issues at the workplace
2) The person identified by the employer as the primary health manager (in case of two or more health managers)

Inclusion criteria for observation targets
1) Adult employees aged 20 years or older
2) Employees who belong to companies that agree to participate in the trial

Key exclusion criteria

None

Target sample size

6


Research contact person

Name of lead principal investigator

1st name Taichi
Middle name
Last name Shimazu

Organization

National Cancer Center Institute for Cancer Control

Division name

Division of Behavioral Sciences

Zip code

104-0045

Address

5-1-1 Tsukiji Chuo-ku Tokyo, Japan

TEL

03-3547-5201

Email

tshimazu@ncc.go.jp


Public contact

Name of contact person

1st name Junko
Middle name
Last name Saito

Organization

National Cancer Center Institute for Cancer Control

Division name

Division of Behavioral Sciences

Zip code

104-0045

Address

5-1-1 Tsukiji Chuo-ku Tokyo, Japan

TEL

03-3547-5201(ext.3319)

Homepage URL


Email

jsaito@ncc.go.jp


Sponsor or person

Institute

National Cancer Center, Japan

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Cancer Center Institutional Review Board

Address

5-1-1 Tsukiji Chuo-ku Tokyo, Japan

Tel

03-3542-2511

Email

NCC_IRBoffice@ml.res.ncc.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

142

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 07 Month 17 Day

Date of IRB

2020 Year 07 Month 27 Day

Anticipated trial start date

2020 Year 07 Month 29 Day

Last follow-up date

2021 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 07 Month 30 Day

Last modified on

2022 Year 08 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047091


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name